Back to 
UBS Group AG
UBS Group AG
KZIA5 quarters
Position history for UBS Group AG's holdings in KAZIA THERAPEUTICS LTD
Yes. Ubs holds 81,090 shares of KZIA (Kazia Therapeutics), worth $1.1M, as of its Q2 2026 13F filing. It increased the position from 13,934 shares in Q1 2026. Ubs has held KZIA since Q2 2025, across 5 quarterly 13F filings.
Current Value
$1.1M
Current Shares
81,090
Total Value Change
+$1.1M
Total Shares Change
+78,061
Quarter-by-Quarter History
Other major holders of KZIA: Alyeska Investment Group, L.P., Point72 Asset Management, L.P., Ensign Peak Advisors, Inc, BALYASNY ASSET MANAGEMENT L.P.